Impact of hormone receptor status in HER2+ early breast cancer: A paradigm shift in the trastuzumab era

Authors :: Nicolas Chopin
S. Giard
Eric Lambaudie
Richard Villet
A. De Nonneville
Eva Jouve
Jean-Marie Boher
Emmanuel Barranger
X. Muracciol
Chafika Mazouni
A. Gonçalves
Pierre-Emmanuel Colombo
Monique Cohen
Roman Rouzier
P. Gimbergues
G. Houvenaeghel
A.-S. Azuar
Fabien Reyal
J-M Classe
Emile Daraï
Source :: Annals of Oncology. 29:viii70
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Hormone receptor
Trastuzumab
Internal medicine
Paradigm shift
Medicine
Hematology
business
medicine.drug
Early breast cancer

Full Text Access

Tools